£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

US Liver Cancer Drug Outlook 2016-2021 Econometric Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 83 days · 83 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 11 August 2026 31 August 2026 21 September 2026 11 October 2026 01 November 2026
View at Amazon ↗

Price data last checked 8 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 83 days • 1 price levels

Days at Price
83 days 0 21 42 62 83 £595 Days at Price

Price Analysis

Most common price: £595 (83 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 83 days

Description

This econometric study provides a detailed outlook for liver cancer drugs in the United States from 2016 to 2021. The report focuses on latent demand, providing potential industry earnings (P.I.E.) estimates across approximately 12,700 cities. By analyzing data at the city and state levels, the study offers a granular view of market opportunities. Readers can access specific percent share data for each city relative to its state and the entire United States. These comparative benchmarks help professionals quickly evaluate specific locations against others. The statistical approach and econometric models used in this research serve as a practical resource for developing effective distribution and sales force strategies.

Key Features

Estimates latent demand and potential industry earnings (P.I.E.) for liver cancer drugs across the United States.

Provides detailed data coverage for approximately 12,700 cities to support localized market analysis.

Includes comparative benchmarks showing each city's percent share of its state and the total U.S. market.

Utilizes econometric models to assist in the development of distribution and sales force strategies.

Offers a statistical approach to gauging city-specific performance against national and state benchmarks.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 September 2015
Listed Since
26 May 2016

Similar Products You Might Like

The 2016-2021 Outlook for Liver Cancer Drugs in Japan
99% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
99% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 29 Oct 2026
Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
99% match

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

£520.00 06 Nov 2026
Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
98% match

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

£515.00 07 Nov 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 04 Nov 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026
World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030
98% match

World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030

£790.00 02 Nov 2026
World Outlook for Liver Cancer Therapeutics 2025-2030
98% match

World Outlook for Liver Cancer Therapeutics 2025-2030

Price unavailable
Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study
98% match

Hepatitis C Virus (HCV) Therapeutics Outlook 2016-2021 Study

£595.00 28 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Liver Health Supplements in the United States
98% match

The 2023-2028 Outlook for Liver Health Supplements in the United States

£520.00 03 Sep 2026
The 2023-2028 Outlook for Liver Health Supplements in India
98% match

The 2023-2028 Outlook for Liver Health Supplements in India

£515.00 03 Sep 2026
US Hematology and Oncology Products Market Outlook 2016-2021
98% match

US Hematology and Oncology Products Market Outlook 2016-2021

£595.00 18 Sep 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 06 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
98% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
98% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026
Hematology and Oncology Products in India Outlook 2016-2021
98% match

Hematology and Oncology Products in India Outlook 2016-2021

£595.00 07 Nov 2026
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
98% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China

£595.00 26 Aug 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
98% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 05 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
98% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 08 Nov 2026
The 2021-2026 World Outlook for Liver Disease Treatments
97% match

The 2021-2026 World Outlook for Liver Disease Treatments

£795.00 31 Oct 2026